Inventor · disambiguated record
Matteo Villain
Also filed as: VILLAIN MATTEO
9 granted patents·1 pending application·53 citations·filing 2000–2008
83Inventor score
Files withAMYLIN PHARMACEUTICALS INC4FORNIX BIOSCIENCES N V4ATHERIS LAB DR RETO STOCKLIN E1UNIV GENEVE1
Top patents by PatentIndex Score
10 records- 0189US6310041B1Synthetic complementary peptides and ophthalmologic uses thereofFORNIX BIOSCIENCES N V·Filed 2000·Granted Oct 30, 2001·45 cites·7 claims
- 0269US7884182B2Chemical peptide ligation with three or more componentsAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Feb 8, 2011·2 cites·7 claims
- 0366US7566697B2Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptidesAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Jul 28, 2009·1 cites·6 claims
- 0466US7410806B2Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and useFORNIX BIOSCIENCES N V·Filed 2005·Granted Aug 12, 2008·1 cites·5 claims
- 0566US6762166B2Synthetic complementary peptides and ophthalmologic uses thereofFORNIX BIOSCIENCES N V·Filed 2001·Granted Jul 13, 2004·1 cites·2 claims
- 0653US6960565B2Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and useFORNIX BIOSCIENCES N V·Filed 2003·Granted Nov 1, 2005·2 cites·8 claims
- 0747US7781488B2Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligationAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Aug 24, 2010·0 cites·11 claims
- 0838US7662914B2Native chemical ligation with three or more componentsAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Feb 16, 2010·0 cites·8 claims
- 0929US2008194872A1Purification of polypeptidesUNIV GENEVE·Filed 2008·Application pending·0 cites
- 1021US7420035B2Purification of polypeptidesATHERIS LAB DR RETO STOCKLIN E·Filed 2001·Granted Sep 2, 2008·1 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Matteo Villain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →